Blog

The Presence of a Cancer Causing Chemical in Zantac and other Generics Has Led to a Voluntary Recall

Ranitidine is the generic name for Zantac; The drug could contain a cancer inducing chemical that has already been discovered in a range of blood pressure The Food and Drug Administration (FDA) has assessed whether the presence of the chemical is a health risk in certain   The FDA initiated recalls after detecting the presence … Continue reading “The Presence of a Cancer Causing Chemical in Zantac and other Generics Has Led to a Voluntary Recall”

Zantac Recalls

Thanks to decades of regulatory oversight and pharmacovigilance, we tend to take for granted the quality and safety of our most used medicines. Sometimes, though, the challenges and complexities of ensuring this peace of mind are thrown into the spotlight. Recently, potentially carcinogenic nitrosamine impurities were found to be present in commercially available drug products. … Continue reading “Zantac Recalls”

Denton Pharma, Inc. dba Northwind Pharmaceuticals Voluntarily Recalls All Unexpired Lots of its Ranitidine Tablets and Ceases Distribution, Due to Possible Presence of N-Nitrosodimethylamine (NDMA) Impurity

Jan 8, 2020 Audience: Consumer, Health Professional, Pharmacy January 8, 2020 — Denton Pharma, Inc. dba Northwind Pharmaceuticals, an affiliate of Northwind Pharmaceuticals, LLC (“Northwind”) today announced the voluntary recall of all unexpired lots of Ranitidine Tablets, 150 mg and 300mg, to the consumer level. The recall is in response to the manufacturer’s recall of all unexpired … Continue reading “Denton Pharma, Inc. dba Northwind Pharmaceuticals Voluntarily Recalls All Unexpired Lots of its Ranitidine Tablets and Ceases Distribution, Due to Possible Presence of N-Nitrosodimethylamine (NDMA) Impurity”

Potential Zantac Plaintiffs

Prospective Zantac plaintiffs will include anyone who used Zantac on a regular basis for any extended period of time and was subsequently diagnosed with cancer. The strongest plaintiffs will be those diagnosed with specific types of cancer that are closely linked to NDMA and the gastrointestinal system which Zantac impacts. These include: Liver cancer Stomach … Continue reading “Potential Zantac Plaintiffs”

Does Zantac Cause Cancer?

In April 2019, an independent pharmaceutical testing lab, Valisure, conducting quality and safety testing and analysis on Zantac and its generic equivalents. The Valisure testing found that ranitidine (the active ingredient in Zantac) contained shockingly high levels of a toxic chemical called NDMA. NDMA (N-nitrosodimethylamine) is a chemical byproduct that results from certain modern manufacturing … Continue reading “Does Zantac Cause Cancer?”